Derivation of hepato-pancreatic intermediate progenitor cells from a clonal mesenchymal stem cell line of rat bone marrow origin

11Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

Abstract

We have recently established a clonal mesenchymal stem cell line (rBM25/ S3) from adult rat bone marrow. The cells have practically unlimited proliferation capacity (over 300 PDL), maintaining multipotency for differentiation. In the present study, we examined the potential for rBM25/S3 cells to differentiate into insulin-secreting cells. When cultured in the presence of HGF and FGF-4 on Matrigel, rBM25/S3 cells expressed genes specific to pancreatic ß-cells as well as those specific to hepatocytes. They still maintained proliferation capacity with a doubling time of ∼30 h. These hepato-pancreatic intermediate progenitor cells, but not the original undifferentiated rBM25/S3 cells, were induced by the overexpression of PDX-1 to produce significant amounts of insulin in a manner responding to glucose concentration in medium. The present culture system indicates a direction for further studies aimed at the realization of cell transplantation therapy for type I diabetes mellitus.

Cite

CITATION STYLE

APA

Masaka, T., Miyazaki, M., Du, G., Hardjo, M., Sakaguchi, M., Takaishi, M., … Huh, N. H. (2008). Derivation of hepato-pancreatic intermediate progenitor cells from a clonal mesenchymal stem cell line of rat bone marrow origin. International Journal of Molecular Medicine, 22(4), 447–452. https://doi.org/10.3892/ijmm_00000041

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free